Tag Archives: World Trade Organization

Drug and duplicity

Posted on May 2, 2012 by

Source: Frontline Brook K. Baker 21 April 2012 NOVARTIS has long been suing the Government of India to eliminate or weaken Section 3(d) of the Patents (Amendment) Act, 2005, which established strict standards of patentability in order to prevent the … Continue reading →

Posted in Compulsory Licensing, Indian Patent Law, IP Rights, Novartis Case, Sec 3 (d), TRIPS flexibilities | Tagged , , , | Leave a comment

A big step forward

Posted on May 2, 2012 by

Source: Frontline C.P. CHANDRASEKHAR 21 April 2012 That this is the first time a compulsory licence has been granted in India is in itself important. H. VIBHU P.H. Kurian, who, on his last day in office as Controller General of … Continue reading →

Posted in Compulsory Licensing, Indian Patent Law, TRIPS flexibilities | Tagged , , , | Leave a comment

India opposes pharma piracy pact by 10 nations

Posted on March 3, 2012 by

Source: The Economic Times 3 March 2012 NEW DELHI: India has strongly opposed an anticounterfeiting trade agreement by a small group of countries including the US, Switzerland, Canada and Japan recently, which it feels will be used to stop the … Continue reading →

Posted in ACTA, seizures, TRIPS | Tagged , , | 1 Comment

EU-India FTA: Shrouded in secrecy, it’s certainly not in our interest

Posted on February 19, 2012 by

by KM Gopakumar Feb 19, 2012 Source: First Post The Free Trade Agreement (FTA) between the European Union (EU) and India was one of the key issues at the 12th EU-India Summit, held in Delhi on 10 February. The present FTA, … Continue reading →

Posted in Border measures, data exclusivity, EU-India FTA, IPR Enforcement | Tagged | Leave a comment

MSF Campaign for Access to essential medicines: Stop Novartis

Posted on February 15, 2012 by

Date Published: 14/02/2012 09:45 Tell pharmaceutical giant Novartis that people matter more than profits. Novartis is taking the Indian government to court to stop the production of affordable medicines by generic drug manufacturers. Millions of people in developing countries depend … Continue reading →

Posted in access to medicines, EU-India FTA, Generic drug, HIV/Aids, Novartis Case | Tagged , , | Leave a comment

Poser over medicine supplies:GLOBAL TRENDS

Posted on January 9, 2012 by

By MARTIN KHOR Source: The Star January 9, 2012 Patients worldwide suffering from various ailments have benefited from cheap generic Indian drugs. But will Indian companies be able to supply new drugs in the future? INDIA may be more famous … Continue reading →

Posted in Compulsory Licensing, EU-India FTA, Mergers and Acquisitions, TRIPS, TRIPS flexibilities, TRIPS plus | Tagged , , | Leave a comment

Press Release: The Treatment Action Campaign (TAC) calls on government to amend South Africa’s Patents Act and protect our right to health

Posted on November 17, 2011 by

17_Nov-2011 (Cape Town) – Ten years ago this week, member countries of the World Trade Organisation (WTO) signed the Declaration on the TRIPS Agreement and Public Health (“the Doha Declaration”). Members were gathered in Doha to discuss valid concerns that … Continue reading →

Posted in Compulsory Licensing, Doha Declaration, Drug Pricing, Generic drug, South Africa's Patent Act, TRIPS, TRIPS plus | Tagged , , | Leave a comment

Policy Brief: The Doha Declaration on TRIPS and Public Health Ten Years Later: The State of Implementation

Posted on November 16, 2011 by

This policy brief by South Centre seeks to examine the implementation of the Doha Declaration in the ten years since its adoption and the challenges of implementing the TRIPS flexibilities for ensuring access to affordable medicines. This brief also analyses … Continue reading →

Posted in August 30 decision, Doha Declaration, TRIPS flexibilities | Tagged , | Leave a comment

ITPC Groups Launch Global Campaign Against Abbott Labs’ Monopoly on Critical AIDS Medicine

Posted on November 10, 2011 by

Public Health Groups Launch Global Campaign Against Abbott Labs’ Monopoly on Critical AIDS Medicine Groups Seek Generic Competition for Abbott’s Patented Lifesaving Treatments WASHINGTON, D.C. – Today, public health groups in a dozen countries launch a campaign to challenge Abbott … Continue reading →

Posted in Drug Pricing, Generic drug, HIV/Aids, patent | Tagged , , , , , | 1 Comment

BIT(s) by bit

Posted on November 10, 2011 by

by Shalini Bhutani | November 09, 2011 Source: mylaw.net Bilateral investment treaties (“BITs”) and other free trade agreements (“FTAs”) have emerged as the way forward for countries to craft their trade and economic relations. BITs are intended to facilitate the … Continue reading →

Posted in BITS, EU-India FTA | Tagged , , | Leave a comment